Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
We have previously shown that absence of the mouse mdr1a (also called mdr3) P-glycoprotein in mdr1a (-/-) "knockout" mice has a profound effect on the tissue distribution and elimination of vinblastine and ivermectin, and hence on the toxicity of these compounds. We show here that the mouse mdr1a and the human MDR1 P-glycoprotein actively transport ivermectin, dexamethasone, digoxin, and cyclosporin A and, to a lesser extent, morphine across a polarized kidney epithelial cell layer in vitro. Injection of these radio-labeled drugs in mdr1a (-/-) and wild-type mice resulted in markedly (20- to 50-fold) higher levels of radioactivity in mdr1a (-/-) brain for digoxin and cyclosporin A, with more moderate effects for dexamethasone (2- to 3-fold) and morphine (1.7-fold). Digoxin and cyclosporin A were also more slowly eliminated from mdr1a (-/-) mice. Our findings show that P-glycoprotein can be a major determinant for the pharmacology of several medically important drugs other than anti-cancer agents, especially in the blood-brain barrier. These results may explain a range of pharmacological interactions observed between various drugs in patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
The Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 8,209
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
Self-citationTHE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE
Endicott, J. A., & Ling, V. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.001033 · Cited by 2,071
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Tsuruo, T., Iida, H., Tsukagoshi, S., & Sakurai, Y. (1981) · PubMed · Cited by 1,459
Expression of Multidrug Resistance Gene in Human Cancers
Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S.-L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., et al. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.2.116 · Cited by 1,290
Gros, P., Croop, J., & Housman, D. (1986) · Cell · doi:10.1016/0092-8674(86)90594-5 · Cited by 1,031
Pharmacology of drugs that alter multidrug resistance in cancer.
Ford, J. M., & Hait, W. N. (1990) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00045-6 · Cited by 974
The Pharmacological Basis of Therapeutics
Faddis, M. O., Goodman, L., & Gilman, A. (1941) · The American Journal of Nursing · doi:10.2307/3414719 · Cited by 929
Human P-glycoprotein transports cyclosporin A and FK506.
Saeki, T., Ueda, K., Tanigawara, Y., Hori, R., & Komano, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53221-x · Cited by 684
Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.
Ueda, K., Okamura, N., Hirai, M., Tanigawara, Y., Saeki, T., Kioka, N., Komano, T., & Hori, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35757-0 · Cited by 673
Dalton, W. S., Grogan, T. M., Meltzer, P. S., Scheper, R. J., Durie, B. G., Taylor, C. W., Miller, T. P., & Salmon, S. E. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.4.415 · Cited by 556
Aoyama, T., Yamano, S., Waxman, D. J., Lapenson, D. P., Meyer, U. A., Fischer, V, Tyndale, R., Inaba, T., Kalow, W., Gelboin, H. V., et al. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81632-5 · Cited by 482
Suthanthiran, M., & Strom, T. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408113310606 · Cited by 469
Croop, J. M., Raymond, M., Haber, D., Devault, A., Arceci, R. J., Gros, P., & Housman, D. E. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.3.1346 · Cited by 463
P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma
Chan, H. S. L., Haddad, G., Thorner, P. S., DeBoer, G., Lin, Y. P., Ondrusek, N., Yeger, H., & Ling, V. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252304 · Cited by 441
Choi, K., Chen, C.-J., Kriegler, M., & Roninson, I. B. (1988) · Cell · doi:10.1016/0092-8674(88)90568-5 · Cited by 423
Devault, A., & Gros, P. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.4.1652 · Cited by 418
How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture.
Gottesman, M. M. (1993) · PubMed · Cited by 416
Boesch, D., Gavériaux‐Ruff, C., Jachez, B., Pourtier, A., Bollinger, P., & Loor, F. (1991) · PubMed · Cited by 391
Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies.
Georges, E., Bradley, G., Gariepy, J., & Ling, V (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.152 · Cited by 384
P-glycoprotein expression and function in circulating blood cells from normal volunteers
Klimecki, W., Futscher, B., Grogan, T., & Dalton, W. (1994) · Blood · doi:10.1182/blood.v83.9.2451.2451 · Cited by 353
Tanigawara, Y., Okamura, N., Hirai, M., Yasuhara, M., Ueda, K., Kioka, N., Komano, T., & Hori, R. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10423-0 · Cited by 337
Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.
Slater, L. M., Sweet, P., Stupecky, M., & Gupta, S. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112450 · Cited by 316
Lum, B. L., Kaubisch, S., Yahanda, A. M., Adler, K. M., Jew, L., Ehsan, M. N., Brophy, N. A., Halsey, J., Gosland, M. P., & Sikic, B. I. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.10.1635 · Cited by 299
Arceci, R. J., Croop, J. M., Horwitz, S. B., & Housman, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4350 · Cited by 265
Schinkel, A. H., Roelofs, E. M., & Borst, P. (1991) · PubMed · Cited by 250
Self-citationHsu, S. I., Lothstein, L., & Horwitz, S. B. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80173-9 · Cited by 237
N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein.
Schinkel, A. H., Kemp, S., Dollé, M., Rudenko, G., & Wagenaar, E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53199-9 · Cited by 214
Self-citationHorio, M., Chin, K. V., Currier, S. J., Goldenberg, S., Williams, C., Pastan, I., Gottesman, M. M., & Handler, J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63784-6 · Cited by 196
Gros, P., Dhir, R., Croop, J., & Talbot, F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7289 · Cited by 185
Modulation of multidrug resistance: at the threshold.
Sikic, B. I. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.9.1629 · Cited by 182
Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells
Callaghan, R., & Riordan, J. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82357-2 · Cited by 162
Bourgeois, S. (1993) · Molecular Endocrinology · doi:10.1210/me.7.7.840 · Cited by 113
Ketoconazole Effectively Reverses Multidrug Resistance in Highly Resistant KB Cells
Siegsmund, M. J., CARDARELLI, C. O., Aksentijevich, I., Sugimoto, Y., Pastan, I. H., & Gottesman, M. M. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)34999-6 · Cited by 86
Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein
Shirai, A., Naito, M., Tatsuta, T., Dong, J., Hanaoka, K., Mikami, K., Oh‐hara, T., & Tsuruo, T. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)90047-7 · Cited by 82
Pelkonen, O., & Breimer, D. D. (1994) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-78680-8_10 · Cited by 36
Cited by
Daneman, R., & Prat, A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020412 · Cited by 3,437
“Mdr1, also called P-glycoprotein, has been widely studied in this context, and knockout mice show an increase in a wide variety of small lipophilic drugs entering the brain, as well as endogenous molecules (Schinkel et al. 1994, 1995, 1996).”
BackgroundBrain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614
“Mutant mice with a genetic disruption of the mdr1a gene show increased accumulation of [(3)H]dexamethasone in the brain (90).”
BackgroundBrain corticosteroid receptor balance in health and disease
de Kloet, E. R. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.269 · Cited by 2,614
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Mammalian ABC Transporters in Health and Disease
Borst, P., & Elferink, R. O. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.102301.093055 · Cited by 1,571
Self-citation
Metadata
- Authors
- Schinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A., & Borst, P.
- Venue
- Journal of Clinical Investigation
- Published
- 1995-10-01
- Volume
- 96
- Issue
- 4
- Pages
- 1698-1705
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2136564762
- Cited by
- 1,107
- References
- 42
- FWCI
- 15.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.